outcomes
Although developments in cancer immunotherapy (immuno-oncology or I-O) continue to improve targeted treatments for patients with cancers such as melanoma and non-small cell lung cancer (NSCLC), there is an ongoing need for education that improves...
By: Melissa Kelly, PhD; Joseph Kim, MD, MPH, MBA, FACHE, CPHQ, FACEHP; and Meredith Engel, MA
outcomes
This article examines the outcomes of our experiment, offering valuable insights for both grant applicants and industry supporters. By sharing our successes, challenges and lessons learned, we hope to contribute to the ongoing improvement of...
By: Sharon E. Cathcart, CHCP; Pam Beaton, PhD, CHCP, FACEHP; Dustin Ensign, CHCP, FACEHP; Andrew Crim, M.Ed., CHCP, FACEHP; and Ann Lichti, CHCP, FACEHP
outcomes
In part four of our ongoing series “Advancing Continuing Medical Education: Reflecting on the Past and Charting a Path Forward,” we shift focus to outcomes measurement as an integrated part of the educational design, identifying the...
By: Emily Belcher and Wendy Cerenzia, MS
outcomes
We hypothesized that CE based in knowledge acquisition (the independent variable) can directly impact practice change (the dependent variable) if designed with probing motivational decision science material.
By: John Ruggiero, PhD, MPA, Antonio B. Meo, CHCP, M. Theresa Bishay, PharmD, Brigitte Azzi, PharmD, Osarumen Urhoghide, PharmD, and Gail Malnarick
outcomes
We hypothesized that CE based in knowledge acquisition (the independent variable) can directly impact practice change (the dependent variable) if designed with probing motivational decision science material.
By: John Ruggiero, PhD, MPA, Antonio B. Meo, CHCP, M. Theresa Bishay, PharmD, Brigitte Azzi, PharmD, Osarumen Urhoghide, PharmD, and Gail Malnarick
outcomes
In this Q+A, Jim Palatine, RPh, MBA talks with panelists Karyn Ruiz-Cordell, MA, PhD, and Kate Biles, CHC on ‘Reframing the Dialogue to Achieve NextGen Outcomes Reports.’
By: Moderator: Jim Palatine, RPh, MBA; Panelists: Karyn Ruiz-Cordell, MA, PhD; Kate Biles, CHCP
outcomes
To support broad initiatives to improve the health of the public through the education of healthcare providers and patients, the Alliance and Pfizer partnered to create project opportunities focused on increasing immunization rates of adults aged...
By: An Alliance and Pfizer Partnership
outcomes
This project aimed to improve pneumococcal vaccine protection for high-risk patients in the University of Arkansas for Medical Sciences multiple myeloma and rheumatology clinics. Read about the interventions, accomplishments and impact of...
By: Lea A. Mabry, M.Ed.; Alison Caballero, MPH, CHES; Mary Burgess, MD; Timothy Atkinson, EdD; Richelle Thompson, EdS; Robert Hopkins Jr., MD, MACP, FAAP
outcomes
The overall project goal is to affect changes to improve pneumococcal vaccination uptake and patient care in three ambulatory specialty practices at a tertiary university medical center.
By: Andrzej Kulczycki, PhD